G protein-coupled receptors in the spotlight;Les récepteurs couplés aux protéines G dans la lumière

Medecine/Sciences

Volumn 28, Issue 10, 2012, Pages 876-882

  Lebon, Guillaume ^a   Tate, Christopher ^b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN QUATERNARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84867710042     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20122810017     Document Type: Review

References (43)

1. Gloriam DE, Fredriksson R, Schioth HB. The G protein-coupled receptor subset of the rat genome. BMC Genomics 2007; 8 : 338.
2. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol 2007 ; 69 : 483-510.
3. Kobilka BK, Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007 ; 28 : 397-406. (Pubitemid 47087966)
4. Dror RO, Arlow DH, Borhani DW, et al. Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations. Proc Natl Acad Sci USA 2009 ; 106 : 4689-94.
5. Katritch V, Cherezov V, Stevens RC. Diversity and modularity of G proteincoupled receptor structures. Trends Pharmacol Sci 2012 ; 33 : 17-27.
6. Deupi X, Standfuss J. Structural insights into agonist-induced activation of G-protein-coupled receptors. Curr Opin Struct Biol 2011 ; 21 : 541-51.
7. Kobilka BK. Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci 2011 ; 32 : 213-8.
8. Choe HW, Park JH, Kim YJ, Ernst OP. Transmembrane signaling by GPCRs: insight from rhodopsin and opsin structures. Neuropharmacology 2011 ; 60 : 52-7.
9. Rasmussen SG, Choi HJ, Rosenbaum DM, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007 ; 450 : 383-7. (Pubitemid 350126755)
10. Tate CG, Schertler GF. Engineering G protein-coupled receptors to facilitate their structure determination. Curr Opin Struct Biol 2009 ; 19 : 386-95.
11. Hanson MA, Cherezov V, Griffith MT, et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 2008 ; 16 : 897-905. (Pubitemid 351778384)
12. Rosenbaum DM, Cherezov V, Hanson MA, et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007 ; 318 : 1266-73. (Pubitemid 350172885)
13. Cherezov V, Rosenbaum DM, Hanson MA, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007 ; 318 : 1258-65. (Pubitemid 350172884)
14. Wacker D, Fenalti G, Brown MA, et al. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc 2010 ; 132 : 11443-5.
15. Jaakola VP, Griffith MT, Hanson MA, et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008 ; 322 : 1211-7.
16. Chien EY, Liu W, Zhao Q, et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010 ; 330 : 1091-5.
17. Shimamura T, Shiroishi M, Weyand S, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011 ; 475 : 65-70.
18. Wu B, Chien EY, Mol CD, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010 ; 330 : 1066-71.
19. Kruse AC, Hu J, Pan AC, et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 2012 ; 482 : 552-6.
20. Haga K, Kruse AC, Asada H, et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 2012 ; 482 : 547-51.
21. Hanson MA, Roth CB, Jo E, et al. Crystal structure of a lipid G protein-coupled receptor. Science 2012 ; 335 : 851-5.
22. Serrano-Vega MJ, Magnani F, Shibata Y, Tate CG. Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci USA 2008 ; 105 : 877-82. (Pubitemid 351282049)
23. Shibata Y, White JF, Serrano-Vega MJ, et al. Thermostabilization of the neurotensin receptor NTS1. J Mol Biol 2009 ; 390 : 262-77.
24. Magnani F, Shibata Y, Serrano-Vega MJ, Tate CG. Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor. Proc Natl Acad Sci USA 2008 ; 105 : 10744-9.
25. Lebon G, Bennett K, Jazayeri A, Tate CG. Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor. J Mol Biol 2011 ; 409 : 298-310.
26. Warne T, Serrano-Vega MJ, Baker JG, et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008 ; 454 : 486-91.
27. Dore AS, Robertson N, Errey JC, et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 2011 ; 19 : 1283-93.
28. Moukhametzianov R, Warne T, Edwards PC, et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor. Proc Natl Acad Sci USA 2011 ; 108 : 8228-32.
29. Rasmussen SG, Choi HJ, Fung JJ, et al. Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 2011 ; 469 : 175-80.
30. Steyaert J, Kobilka BK. Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol 2011 ; 21 : 567-72.
31. Warne T, Moukhametzianov R, Baker JG, et al. The structural basis for agonist and partial agonist action on a beta1-adrenergic receptor. Nature 2011 ; 469 : 241-4.
32. Rosenbaum DM, Zhang C, Lyons JA, et al. Structure and function of an irreversible agonist-beta2 adrenoceptor complex. Nature 2011 ; 469 : 236-40.
33. Standfuss J, Edwards PC, D'Antona A, et al. The structural basis of agonistinduced activation in constitutively active rhodopsin. Nature 2011 ; 471 : 656-60.
34. Choe HW, Kim YJ, Park JH, et al. Crystal structure of metarhodopsin II. Nature 2011 ; 471 : 651-5.
35. Scheerer P, Park JH, Hildebrand PW, et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008 ; 455 : 497-502.
36. Lebon G, Warne T, Edwards PC, et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 2011 ; 474 : 521-5.
37. Lebon G, Tate CG. Structure tridimensionnelle du récepteur de l'adénosine A2A lié à son agoniste naturel l'adénosine. Med Sci (Paris) 2011 ; 27 : 926-8.
38. Xu F, Wu H, Katritch V, et al. Structure of an agonist-bound human A2A adenosine receptor. Science 2011 ; 332 : 322-7.
39. Rasmussen SG, DeVree BT, Zou Y, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011 ; 477 : 549-55.
40. Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000 ; 289 : 739-45. (Pubitemid 30650186)
41. Fritze O, Filipek S, Kuksa V, et al. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci USA 2003 ; 100 : 2290-5. (Pubitemid 36297492)
42. Granier S. Structure des récepteurs mu et delta des opiacés. Med Sci (Paris) 2012 ; 28 : 870-5.
43. Banères JL, Mouillac B. Manipulation des RCPG : expression, purification et stabilisation in vitro. Med Sci (Paris) 2012 ; 28 : 837-44.